OCM
TMO icon

Orleans Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Orleans Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Hold
4,305
– – 1.11% 30
2026
Q1 		$2.12M Hold
4,305
– – 1.43% 25
2025
Q4 		$2.49M Sell
4,305
-595
-12% -$336K 1.55% 20
2025
Q3 		$2.38M Sell
4,900
-1,417
-22% -$660K 1.54% 19
2025
Q2 		$2.56M Buy
6,317
+1,085
+21% +$454K 1.36% 27
2025
Q1 		$2.6M Sell
5,232
-13
-0.2% -$7.04K 1.53% 26
2024
Q4 		$2.86M Sell
5,245
-30
-0.6% -$16.5K 1.6% 24
2024
Q3 		$3.26M Sell
5,275
-100
-2% -$59.2K 1.85% 16
2024
Q2 		$2.97M Sell
5,375
-115
-2% -$65.9K 1.89% 20
2024
Q1 		$3.19M Sell
5,490
-575
-9% -$323K 2.1% 16
2023
Q4 		$3.22M Buy
6,065
+245
+4% +$119K 2.16% 17
2023
Q3 		$2.95M Sell
5,820
-210
-3% -$112K 2.19% 13
2023
Q2 		$3.15M Sell
6,030
-75
-1% -$40.5K 2.23% 13
2023
Q1 		$3.52M Sell
6,105
-85
-1% -$47.9K 2.6% 9
2022
Q4 		$3.41M Buy
6,190
+5
+0.1% +$2.65K 2.61% 12
2022
Q3 		$3.14M Sell
6,185
-285
-4% -$159K 2.62% 10
2022
Q2 		$3.52M Buy
6,470
+30
+0.5% +$16.5K 2.63% 9
2022
Q1 		$3.8M Buy
6,440
+20
+0.3% +$11.5K 2.36% 11
2021
Q4 		$4.28M Buy
6,420
+50
+0.8% +$31.2K 2.43% 12
2021
Q3 		$3.64M Sell
6,370
-60
-0.9% -$32.9K 2.32% 12
2021
Q2 		$3.24M Sell
6,430
-50
-0.8% -$23.6K 2.08% 17
2021
Q1 		$2.96M Buy
6,480
+75
+1% +$35.8K 2.01% 19
2020
Q4 		$2.98M Sell
6,405
-55
-0.9% -$25.8K 2.14% 16
2020
Q3 		$2.85M Buy
6,460
+75
+1% +$31K 2.18% 16
2020
Q2 		$2.31M Buy
+6,385
New +$2.14M 1.89% 17
2020
Q1 		– Sell
-5,410
Closed -$1.76M – 82
2019
Q4 		$1.76M Buy
5,410
+320
+6% +$97K 1.23% 36
2019
Q3 		$1.48M Buy
5,090
+425
+9% +$122K 1.1% 43
2019
Q2 		$1.37M Buy
+4,665
New +$1.28M 1.03% 41

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Orleans Capital Management's TMO Position: Q2 2026 in Review

Orleans Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 4,305 shares worth $2.16M. The position accounts for 1.11% of the portfolio, ranked #30.

Orleans Capital Management first reported a position in TMO in Q2 2019 and has held it in 28 quarters since. The position peaked at $4.28M in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Orleans Capital Management held 4,305 shares of Thermo Fisher Scientific worth $2.16M as of Q2 2026.
  • Orleans Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 1.11% of Orleans Capital Management's portfolio in Q2 2026, its #30 holding.
  • Orleans Capital Management first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 28 quarters since.
  • Orleans Capital Management's Thermo Fisher Scientific position peaked at $4.28M in Q4 2021.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Orleans Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.